For patients with advanced emphysema, EBV is associated with higher mortality and morbidity compared with LVRS.

The adjusted likelihood for an injurious fall in adults with COPD was elevated with a fall-risk increasing drug prescription, ...

Two days before the provincial election campaign kicked off last week, the government and Philpott announced funding with a ...

Red was the hue du jour donned by the staff and residents at Essex Center this week as they participated in a jumping jacks competition among Centers Health Care facilities as part of a comprehensive ...

GSK, a UK-based biopharma, reported strong 2024 results, with a promising shift toward specialty medicines. Read why I ...

Researchers developed a new COPD-ES questionnaire for healthcare professionals to improve the management of stable chronic ...

GSK reports better-than-expected Q4 earnings. It also announces a new share buyback program and raises the long-term sales outlook for 2031 by $2 billion.

During the 43rd J.P. Morgan Annual Healthcare Conference last month, Areteia Therapeutics took centre stage, presenting a ...

New research highlights the significant health care resource utilization burden of generalized pustular psoriasis (GPP), ...

Despite affecting over 30 million Americans, COPD remains dangerously underdiagnosed. As a leading cause of death, this chronic respiratory disease continues to claim lives, yet awareness and early ...